Han T - Search Results

1

Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling.

Wang W, Han T, Tong W, Zhao J, Qiu X. Wang W, et al. Among authors: han t. Onco Targets Ther. 2018 Sep 26;11:6249-6257. doi: 10.2147/OTT.S175606. eCollection 2018. Onco Targets Ther. 2018. PMID: 30288060 Free PMC article.

2

A study on the efficacy of recombinant human endostatin combined with apatinib mesylate in patients with middle and advanced stage non-small cell lung cancer.

Zhao J, Yu H, Han T, Wang W, Tong W, Zhu X. Zhao J, et al. Among authors: han t. J BUON. 2019 Nov-Dec;24(6):2267-2272. J BUON. 2019. PMID: 31983093 Free article.

3

N⁶-methyladenosine (m⁶A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer.

Tang J, Han T, Tong W, Zhao J, Wang W. Tang J, et al. Among authors: han t. Cell Death Discov. 2021 May 17;7(1):108. doi: 10.1038/s41420-021-00488-y. Cell Death Discov. 2021. PMID: 34001850 Free PMC article.

4

Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression.

Zhao J, Yu H, Han T, Zhu X. Zhao J, et al. Among authors: han t. Cancer Manag Res. 2021 Dec 18;13:9261-9270. doi: 10.2147/CMAR.S330357. eCollection 2021. Cancer Manag Res. 2021. PMID: 34955656 Free PMC article.

5

Exploration of uniportal thoracoscopy in esophageal cancer surgery.

Han T, Tong W, Zang B, Xie J, Wang Q, Zhang L. Han T, et al. Panminerva Med. 2023 Sep 21. doi: 10.23736/S0031-0808.23.04948-0. Online ahead of print. Panminerva Med. 2023. PMID: 37733012 Free article. No abstract available.

6

Clinical presentation and treatment of advanced basal-like lung carcinoma.

Xie J, Zhang M, Wang H, Guo X, Han T, Tong W, Liu H, Zhang L. Xie J, et al. Among authors: han t. Panminerva Med. 2024 Feb 26. doi: 10.23736/S0031-0808.24.05069-9. Online ahead of print. Panminerva Med. 2024. PMID: 38407012 Free article. No abstract available.

7

FOXF2 suppressed esophageal squamous cell carcinoma by reducing M2 TAMs via modulating RNF144A-FTO axis.

Han T, Tong W, Xie J, Guo X, Zhang L. Han T, et al. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113422. doi: 10.1016/j.intimp.2024.113422. Epub 2024 Oct 23. Int Immunopharmacol. 2024. PMID: 39447407

8

Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.

Han T, Shu T, Dong S, Li P, Li W, Liu D, Qi R, Zhang S, Zhang L. Han T, et al. Oncol Lett. 2017 May;13(5):2982-2988. doi: 10.3892/ol.2017.5837. Epub 2017 Mar 10. Oncol Lett. 2017. PMID: 28521405 Free PMC article.

9

The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.

Han T, Wang Z, Yang Y, Shu T, Li W, Liu D, Li P, Qi R, Ren Y, Li L, Liu H, Zhang S, Zhang L. Han T, et al. Oncol Rep. 2015 Sep;34(3):1353-60. doi: 10.3892/or.2015.4090. Epub 2015 Jun 26. Oncol Rep. 2015. PMID: 26135942

10

A randomized, crossover trial of one night of oxygen therapy for obstructive sleep apnea in patients with fibrotic interstitial lung disease.

Han T, Xiang BY, Liu ZL, Guo XR, Mao LS, Liu X, Li YM, Zhang XL. Han T, et al. Sleep Breath. 2025 Jan 13;29(1):75. doi: 10.1007/s11325-025-03251-0. Sleep Breath. 2025. PMID: 39804535 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,305 results

Search Page

Filters